肝泡型包虫病的诊治进展  

Progress in diagnosis and treatment of hepatic alveolar echinococcosis

作　　者：王志鑫[1] 刘云飞 王灏 王海久[1] 樊海宁[1] Wang Zhixin;Liu Yunfei;Wang Hao;Wang Haijiu;Fan Haining(Department of Hepatopancreatobiliary Surgery,Affiliated Hospital of Qinghai University,the Research Key Laboratory for Echinococcosis of Qinghai Province,Xining 810012,China)

机构地区：[1]青海大学附属医院肝胆胰外科青海省包虫病研究重点实验室,西宁810012

出　　处：《器官移植》2024年第2期171-177,共7页Organ Transplantation

基　　金：国家自然科学基金(81960576);青海科技厅2022年科技计划项目(青海省包虫病研究重点实验室);青海大学附属医院肝胆外科(包虫病)国家临床重点专科建设项目(青卫健办-125号)。

摘　　要：肝包虫病为慢性寄生虫病,由多房棘球蚴的幼虫引发,此病具有相当高的致残率和死亡风险,又被称作“虫癌”。临床上将肝包虫病分为肝泡型包虫病和肝囊型包虫病,肝包虫病在世界各地广泛流行,我国主要在西部农牧区居民群体中发生,对该地区居民的生存质量构成了巨大的威胁。目前临床上治疗肝包虫病以手术治疗方式为主,伴随着外科诊治技术的迅速发展和对肝包虫病研究不断深入,其诊治方案也不断完善。本文将主要综述肝泡型包虫病的诊断和治疗进展,旨在为临床医务人员提供参考,以尽早发现和治疗,降低疾病对患者产生的不良影响,改善患者预后。Hepatic echinococcosis is a chronic parasitic disease,which is caused by the larvae of Echinococcus multilocularis.It has a high risk of disability and mortality,which is also known as"parasite cancer".In clinical practice,hepatic echinococcosis can be divided into hepatic alveolar echinococcosis and hepatic cystic echinococcosis.Hepatic echinococcosis is widely prevalent worldwide.It mainly occurs in the populations residing agricultural and pastoral areas in western China,posing significant threats to the quality of life of local residents.At present,surgery is the main treatment for hepatic echinococcosis in clinical settings.With rapid development of surgical diagnosis and treatment technology and deepening understanding of hepatic echinococcosis,diagnosis and treatment regimens have also been constantly improved.In this article,research progresses on the diagnosis and treatment of hepatic alveolar echinococcosis were reviewed,aiming to provide reference for clinicians,deliver early diagnosis and treatment,mitigate adverse effects of this disease upon patients and improve clinical prognosis.

关 键 词：肝泡型包虫病 多房棘球蚴 剪切波弹性成像 ^(18)F-氟代脱氧葡萄糖 正电子发射计算机体层显像仪(PET-CT) 肝切除术 肝移植 阿苯达唑 

分 类 号：R617[医药卫生—外科学] R53[医药卫生—临床医学]